JR
Jeffrey Rein
Director

Jeffrey Rein insider trades: MedWorth Acquisition (MWRX) stock buys and sales

Director, MedWorth Acquisition Last trade Jun 26, 2013 23 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
7
Open-market trades
since 2005
2
Companies
last trade 2013

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Jeffrey reports to the SEC

Open-market buys and sales

7 trades reported on SEC Form 4, newest first

DateStockTypeValue
Jun 26, 2013MWRX↑ Buy$150K
Aug 9, 2007WAG↓ Sell$108K
Aug 8, 2007WAG↓ Sell$184K
Jul 20, 2007WAG↓ Sell$271K
Dec 22, 2006WAG↓ Sell$194K
Jul 7, 2006WAG↓ Sell$319K
Aug 4, 2005WAG↓ Sell$336K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Jeffrey Rein's insider trades

Jeffrey Rein is a director at MedWorth Acquisition (MWRX). Since Aug 4, 2005, Jeffrey has reported 1 open-market purchase worth $150K and 6 sales worth $1.4M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include grants and awards (10 filings), gifts (7 filings), option exercises (7 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every MWRX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.